TCL Archive PD-1 Checkpoint Inhibitor Opdivo First to Demonstrate Survival Benefit in Phase III November 28, 2014
TCL Archive In Brief: Thomas Davis Is Named New Director Of NCCP; Senate Subcommittee Give NCI $1.2 Bil. For FY ‘86 September 27, 1985